+ All Categories
Home > Documents > Technology & Strategy GEST-D-484 Manuel Hensmans 1.

Technology & Strategy GEST-D-484 Manuel Hensmans 1.

Date post: 21-Dec-2015
Category:
View: 221 times
Download: 0 times
Share this document with a friend
44
Technology & Strategy GEST-D-484 Manuel Hensmans 1
Transcript
Page 1: Technology & Strategy GEST-D-484 Manuel Hensmans 1.

1

Technology & StrategyGEST-D-484

Manuel Hensmans

Page 2: Technology & Strategy GEST-D-484 Manuel Hensmans 1.

2

First things first…

• Register by 16 February– Fill out your name, year of study and

student id on sheet in class • In capitals, please!

Page 3: Technology & Strategy GEST-D-484 Manuel Hensmans 1.

3

All info on…

• http://technologystrategy.skynetblogs.be/– Slides, readings, syllabus description, guide

to grading, overview course…

Page 4: Technology & Strategy GEST-D-484 Manuel Hensmans 1.

4

Some general references

• Non-compulsory reference textbooks • Strategic Management Of Technological Innovation

(3rd Edition)– Author: Melissa Schelling

• Exploring Corporate Strategy (8th or 9th edition)– Authors: Johnson, Scholes & Whittington

Page 5: Technology & Strategy GEST-D-484 Manuel Hensmans 1.

Overview Course

• Part I: Introduction– Class 1: Overview– Class 2: Introductory strategic concepts

5

Page 6: Technology & Strategy GEST-D-484 Manuel Hensmans 1.

Overview Course

• Part II: Industry dynamics techn innovHow and why innovation occurs in an industry

Why some innovations rise to dominate others– Class 3: Strategic sources of innovation– Class 4: Technological (R)evolution– Class 5: Standard Wars– Class 6: Strategic timing of innovation– Class 7: Class presentations

6

Page 7: Technology & Strategy GEST-D-484 Manuel Hensmans 1.

Overview Course

• Part III: Firm-level strategyHow to formulate techn innovation strategy

How to organize techn innovation strategy– Class 8: Strategic direction– Class 9: Ecosystem strategy – Class 10: E-business strategy – Class 11: Organizing for innovation– Class 12: Class presentations

7

Page 8: Technology & Strategy GEST-D-484 Manuel Hensmans 1.

8

Presentations• Choose a business involved in a tech

innovation• Presentation 1

– Strategic analysis of past dynamics• Describe history technological innovation and

industry dynamics to create & capture value• In terms of relevant theories of Parts I & II

– Focus on rivalry established players & new entrants

Page 9: Technology & Strategy GEST-D-484 Manuel Hensmans 1.

9

Presentations• Presentation 2

– Strategic choices for the future• From the viewpoint of business & recent

technological innovation• in terms of relevant theories of Part III

– What would established players vs new entrants do?– Why would they make such strategic choices?

Page 10: Technology & Strategy GEST-D-484 Manuel Hensmans 1.

10

Examples of choices… non-exhaustive list!• Car industry

– E.g. electrical / hybrid cars• E-businesses

– E.g. social media, insurance,…• Biotech & pharma

– E.g. UCB, biotechinbrussels.be,…• Mature industries under threat

– E.g. newspapers… • ...

Page 11: Technology & Strategy GEST-D-484 Manuel Hensmans 1.

11

Case-study

• On chosen firms– Elaborate on presentations– 6000-8000 words

• Create a group blog to monitor progress of presentations and cases

Page 12: Technology & Strategy GEST-D-484 Manuel Hensmans 1.

12

Marking

• 10 points– class presentations & case-study– participation in class!

• 10 points• 1 question on your case-study• 1 open question

Page 13: Technology & Strategy GEST-D-484 Manuel Hensmans 1.

13

Strategic management of technological innovation

• How to obtain, use or develop technology to achieve a new competitive advantage

or

to defend an existing competitive advantage against erosionLAST C

LASS

How to sustainably create and capture value of innovation

Page 14: Technology & Strategy GEST-D-484 Manuel Hensmans 1.

14

Today1) Tech Strategy different from general

business strategy?– Reading

• « Increasing returns & the new world of business »

2) Main framework for industry analysis– 5 forces framework– Apply to biotechnology industry– Reading

• « Can science be a business?»

Page 15: Technology & Strategy GEST-D-484 Manuel Hensmans 1.

15

Discussion Reading

• Who has read? Discuss!• Why has Nokia dumped its own mobile

operating system Symbian?• Symbian is world leader in market share!

• Android phones– 1 year ago: 1/25th of market– Now: ¼ of market

Page 16: Technology & Strategy GEST-D-484 Manuel Hensmans 1.

16

Increasing returns

• Market instability• More accurate than in text?

– « Those that are growing, will grow more; those that are shrinking, will shrink more »

• Unpredictability• Multiple potential outcomes• Small changes in interdependence, large effects

– Samsung left Symbian, joined Android platform

• Lock-in • Due to customer switching costs

– Inferior product can come to dominate!

Page 17: Technology & Strategy GEST-D-484 Manuel Hensmans 1.

17

Increasing returns

• Winner-takes-it-all tendency• Fat profits for winner(s)

– Others» Either lose everything» Or become complementors to winning platform

Page 18: Technology & Strategy GEST-D-484 Manuel Hensmans 1.

18

Microsoft and the Internet: Explain!

Page 19: Technology & Strategy GEST-D-484 Manuel Hensmans 1.

19

Talk of a « New Economy »

• New Economy?– Post-1995 acceleration

• Exponential growth in computer speed, memory & interconnectedness

• Development of the Internet

– Frictionless economy? • No inflation of costs, no diminishing returns…

• What do you think?• «The computer chip has transformed us at least as much as

the advent of electricity or internal combusion engines »

Page 20: Technology & Strategy GEST-D-484 Manuel Hensmans 1.

20

Stock market crash

0

500

1000

1500

2000

2500

3000

3500

4000

4500

5000

Year1995 1996 1997 1998 1999 2000 2001 2002 20031994

NASDAQ Points

Launch of Amazon.com

Normalization? Pre-internet computers Rise of the Internet

321

– 45%

2004 2005 2006

4

2007

Page 21: Technology & Strategy GEST-D-484 Manuel Hensmans 1.

21

Only true to some extent

• Not jobless technologies…• Limitations on human attention & time• Substitution one technology for another?

• Productivity revival new economy?• Primarily computer hardware, telecom…

» With spillover to 12% economy involving manufacture durable goods

• Mostly in US, not in Europe!– Why?

• Greatest benefits computers in the past?

Page 22: Technology & Strategy GEST-D-484 Manuel Hensmans 1.

22

Jobless technology possible?

• See article on 3D manufacturing technology– Appeared in The Economist– See http://technologystrategy.skynetblogs.be/

Page 23: Technology & Strategy GEST-D-484 Manuel Hensmans 1.

23

In sum: technology strategy

• How different from business strategy?– more uncertainty

• very small portion new tech leads to new products/processes

– more use of intellectual property management• R&D, protection & translation tacit knowledge

– probability of radically new products/services• bigger opportunities for new ventures

Page 24: Technology & Strategy GEST-D-484 Manuel Hensmans 1.

24

In sum: technology strategy

• How different from business strategy?– alignment needed with HR/organizational

dynamics• E.g. • especially if basic scientific R&D is involved

– Tension customer orientation vs technological discovery?

– in some aspects different decision-making• Standards, increasing returns, tipping points, first

mover advantage…

Page 25: Technology & Strategy GEST-D-484 Manuel Hensmans 1.

2nd part class: Industry analysis

• What is an “industry”?• Firms producing similar principal products/services

• 2 goals of industry analysis?– Assess attractiveness industry structure

• Should we get in or out?

– Can we shape industry structure in our favour • Once in, can we improve or not?

25

Page 26: Technology & Strategy GEST-D-484 Manuel Hensmans 1.

26

Read article + Break

• Read hand-out – « Can science be a business? »

• Think about the attractiveness of the biotech industry

• Think about the industry structure and how it could be changed

Page 27: Technology & Strategy GEST-D-484 Manuel Hensmans 1.

Industry analysis: 5 forces

27

COMPETITIVE RIVALRYSuppliers

Potential entrants

Buyers

Substitutes

THREAT OF ENTRY

THREAT OF SUBSTITUTES

POWER BUYERS

POWER SUPPLIERS

Page 28: Technology & Strategy GEST-D-484 Manuel Hensmans 1.

28

Page 29: Technology & Strategy GEST-D-484 Manuel Hensmans 1.

29

Page 30: Technology & Strategy GEST-D-484 Manuel Hensmans 1.

1 Competitive rivalry • Among existing competitors

– Competitor balance• Numerous or roughly equal in size & power?

– Industry growth • Slow often means fierce rivalry• Fast could mean rivalry about profit is still coming!

– Fixed costs• High often means fierce rivalry

– Exit barriers• High tends to increase rivalry (esp declining ind)

– Low differentiation?30

Page 31: Technology & Strategy GEST-D-484 Manuel Hensmans 1.

31

Global biotech industry

• Competitive rivalry?

– Large number of biotech startups and SMEs– Alongside small number of large companies

• Novartis, Roche,...

• High fixed costs• Few companies make profit• Struggle to discover « biotech blockbuster »

– >Overall moderately strong rivalry

Page 32: Technology & Strategy GEST-D-484 Manuel Hensmans 1.

2 Threat of Entry• Height entry barriers

– Economies of scale and experience• Automobiles, advertising FMCG, pharma

– But Internet banking (only 10,000 customers to be viable)

– Expected retaliation• Price war or marketing blitz; global retaliation

– E.g. Coca-Cola or videogame industry

– Access to supply or distribution channels• Bypassed by Dell and Amazon

– Legislation or government action– Lengthy & costly clinical trials in biotech industry

32

Page 33: Technology & Strategy GEST-D-484 Manuel Hensmans 1.

2 Threat of Entry • Height entry barriers

– Switching costs customer• Long-distance telephone vs Skype

– Diversification from other markets• Leverage existing resources and capabilities

– Apple and music distribution

33

Page 34: Technology & Strategy GEST-D-484 Manuel Hensmans 1.

34

Global biotech industry

• Threat of entry– Strong growth, but high entry barriers!

• Strong intellectual property protection• Most biotech start-ups are…

– Academic research spin-offs» Long start-up periods with little profit» High fixed costs

– But pharma diversifying into biotech!

– > Moderately strong threat

Page 35: Technology & Strategy GEST-D-484 Manuel Hensmans 1.

3 Threat of substitutes

• Price/performance ratio• Alumnium vs steel in automobile applications• Videoconferencing vs travel

• Extra-industry influences– Always present, always take into account!

• Demand wired teleph lines in emerging economies– Capped due to choice for wireless mobilies– How many people have mobile phone access?

35

Page 36: Technology & Strategy GEST-D-484 Manuel Hensmans 1.

36

Global biotech industry

• Threat of substitutes?– Medical biotech

• conventional therapeutic drugs– Less effective than biotech drugs

• BUT! New threat of « biosimilars»– http://www.economist.com/node/17316667– Traditional pharma

» Owner becomes poacher

• At the moment, moderate threat

Page 37: Technology & Strategy GEST-D-484 Manuel Hensmans 1.

4 Power of Buyers

• Power of buyers (not necess ultimate customers)

– Concentrated buyers• Telecoms didn’t want Nokia to partner with Google

– Low switching costs• Low for weakly differentiated commodities

– Steel, mobile phones (not smartphones)...

– Buyer competition threat• Buyer own supply facilities?

– Threat of backward vertical integration» E.g. window manufacturers against glass manufact

37

Page 38: Technology & Strategy GEST-D-484 Manuel Hensmans 1.

38

Global biotech industry• Power of buyers?

– Main buyers are…• Medical biotech

– Healthcare providers such as GP doctors, hospitals,…

• Agricultural biotech– Farmers, growers…

– One company ownership of innovation• Patent protected = Less buyer power

– Reference pricing imposed by government • More buyer power

– > Overall…moderate threat

Page 39: Technology & Strategy GEST-D-484 Manuel Hensmans 1.

5 Power of Suppliers

• Power of suppliers– Concentrated suppliers

• Iron ore industry: 3 main producers– Fragmented steel companies: weak bargaining power

– High switching cost• Microsoft’s operating system

– Buyers prepared to pay premium to avoid hassle

– Supplier competition threat• Foward vertical integration: e.g. on-line booking

– Low-cost airlines cut out travel agencies

39

Page 40: Technology & Strategy GEST-D-484 Manuel Hensmans 1.

40

Global biotech industry

• Power of suppliers?– Major suppliers are

• Manufacturers of lab equipment, software publishers, chemical companies …

• Little differentiation between suppliers– Less supplier power

• Yet, more supplier power– small likelihood backward integration– buyers can’t substitute certain raw material or equipment

– > Moderate threat

Page 41: Technology & Strategy GEST-D-484 Manuel Hensmans 1.

Industry analysis: difficulty!

• Define the right industry– Different market segments

• E.g. Biotech industry

– Converging industries • Pharma (marketing) & biotech (discovery)• Telephone & photographic

– Kodak vs Nokia or Samsung

– Complementors (sixth force?)• 1+1>2

– Dell and Microsoft ()– ARM & Apple

41

Page 42: Technology & Strategy GEST-D-484 Manuel Hensmans 1.

42

Biotech market segementation (2009 data)

Page 43: Technology & Strategy GEST-D-484 Manuel Hensmans 1.

Competition and Collaboration

43

Achieve accredited supplier status

e.g. Microsoft ecosystem (or business

schools)

Fragmented nature of doctors and hospitals good

for pharma!BUT collaboration with centralized government

drug-specifying agencies

Trade associations may promote safety standards or

technical specifications

Internet customer self-service, co-creation or

customizatione.g. Amazon, Made.com (on-line furniture retailer),

Dell

Collaborative timingMicrosoft MS-DOS OS & IBM’s personal computer

Page 44: Technology & Strategy GEST-D-484 Manuel Hensmans 1.

44

To read for next class

• “Is the Internet a US invention?”– By David C. Mowery & Timothy Simcoe

• Research Policy 31 (2002), pp. 1369–1387

• Additional reading if you have time…– “China vs the World”

• By Hout and Ghemawat– Harvard Business Review, December 2010


Recommended